文献速递消化道肿瘤与早癌消化内镜

全层瘢痕切除作为R1/Rx切除T1结直肠癌的替代完成手术策略

Full-Thickness Scar Resection After R1/Rx Excised T1 Colorectal Cancers as an Alternative to Completion Surgery.
PubMed 文献 · Am J Gastroenterol · 2022-01-01

该研究比较了T1结直肠癌局部切除后切缘阳性或无法评估(R1/Rx)且无其他危险因素的患者,接受全层瘢痕切除(FTRS)与完成手术(CS)的长期肿瘤学结局。结果显示FTRS组无病生存率较低(89.9% vs 96.8%,P=0.019),但转移无生存率和总生存率无显著差异,且多数复发可 salvage 手术。作者认为FTRS可作为CS的替代策略。

要点

  • T1结直肠癌局部切除后R1/Rx且无脉管侵犯或低分化者,FTRS组无病生存率低于CS组(89.9% vs 96.8%,P=0.019)。
  • FTRS组复发率9.0%(95%CI 3.9%-17.7%),CS组2.2%(95%CI 0.9%-4.6%),8例FTRS复发中5例可 salvage 手术。
  • 两组转移无生存率(92.1% vs 96.8%,P=0.10)和总生存率(94.4% vs 95.6%,P=0.55)无显著差异。

核心结论

  • 对于T1结直肠癌局部切除后R1/Rx且无脉管侵犯或低分化者,FTRS后监测并在复发时行 salvage 手术,可能是CS的有效替代策略。

研究设计与样本

  • 大型队列研究,纳入2000至2017年间连续T1结直肠癌患者,筛选出宏观完整局部切除但组织学切缘阳性或无法评估(R1/Rx)且无脉管侵犯或低分化者,比较CS与FTRS。
  • 共3697例T1结直肠癌患者,434例符合纳入标准(平均年龄66岁,61%男性),其中334例接受CS,100例接受FTRS。

主要发现

  • 中位随访64个月,CS组7例(2.2%,95%CI 0.9%-4.6%)出现结直肠癌复发,FTRS组8例(9.0%,95%CI 3.9%-17.7%)。
  • FTRS组无病生存率低于CS组(89.9% vs 96.8%,P=0.019)。
  • FTRS组8例复发中5例可接受 salvage 手术。
  • 两组转移无生存率(FTRS 92.1% vs CS 96.8%,P=0.10)和总生存率(FTRS 94.4% vs CS 95.6%,P=0.55)无显著差异。

临床怎么用

  • 作者认为,对于T1结直肠癌局部切除后R1/Rx作为唯一危险因素者,FTRS后监测并在复发时行 salvage 手术,可能是CS的有效替代策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Local full-thickness resections of the scar (FTRS) after local excision of a T1 colorectal cancer (CRC) with uncertain resection margins is proposed as an alternative strategy to completion surgery (CS), provided that no local intramural residual cancer (LIRC) is found. However, a comparison on long-term oncological outcome between both strategies is missing. METHODS: A large cohort of patients with consecutive T1 CRC between 2000 and 2017 was used. Patients were selected if they underwent a macroscopically complete local excision of a T1 CRC but positive or unassessable (R1/Rx) resection margins at histology and without lymphovascular invasion or poor differentiation. Patients treated with CS or FTRS were compared on the presence of CRC recurrence, a 5-year overall survival, disease-free survival, and metastasis-free survival. RESULTS: Of 3,697 patients with a T1 CRC, 434 met the inclusion criteria (mean age 66 years, 61% men). Three hundred thirty-four patients underwent CS, and 100 patients underwent FTRS. The median follow-up period was 64 months. CRC recurrence was seen in 7 patients who underwent CS (2.2%, 95% CI 0.9%-4.6%) and in 8 patients who underwent FTRS (9.0%, 95% CI 3.9%-17.7%). Disease-free survival was lower in FTRS strategy (96.8% vs 89.9%, P = 0.019), but 5 of the 8 FTRS recurrences could be treated with salvage surgery. The metastasis-free survival (CS 96.8% vs FTRS 92.1%, P = 0.10) and overall survival (CS 95.6% vs FTRS 94.4%, P = 0.55) did not differ significantly between both strategies. DISCUSSION: FTRS after local excision of a T1 CRC with R1/Rx resection margins as a sole risk factor, followed by surveillance and salvage surgery in case of CRC recurrence, could be a valid alternative strategy to CS.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gijsbers KM, Laclé MM, Elias SG, et al. Full-Thickness Scar Resection After R1/Rx Excised T1 Colorectal Cancers as an Alternative to Completion Surgery. Am J Gastroenterol. 2022. PMID: 35029166. doi:10.14309/ajg.0000000000001621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。